AOK Nordost - Die Gesundheitskasse, Wilhelmstr. 1, 10963, Berlin, Germany.
Hannover Medical School, Institute for Epidemiology, Social Medicine and Health Systems Research, Carl-Neuberg-Str. 1, 30625, Hanover, Germany.
BMC Health Serv Res. 2020 Mar 16;20(1):217. doi: 10.1186/s12913-020-05088-7.
The "AOK-Junior" care program of the AOK Nordost (a German statutory health insurance) completes the primary care for children and adolescents (C&A) in the federal states of Berlin, Brandenburg and Mecklenburg-Vorpommern in Germany. The focus of this program is on prevention and early detection of illness on C&A. Furthermore, the aim is to maintain the health of C&A and to prevent, detect and treat illness on time. Elements of the program are not only the integrated care of C&A, but also, for example, weight reduction and additional medical checkups U10, U11 and J2. The evaluation of the complex intervention should provide information about the effectiveness of early disease detection and costs-effectiveness as well as of other parameters like satisfaction.
The evaluation is performed on the levels of structural-, process- and results-quality. The cost effectiveness is also assessed by means of a health economic evaluation. In addition to the collection of qualitative and quantitative primary data from participating and non-participating C&A and paediatricians, routine data from a statutory health insurance are used in the evaluation. Furthermore, a cross-sectional design is used to evaluate the structure and process quality. The effectiveness is evaluated in longitudinal section design on the basis of the secondary data. The quantitative surveys include net n = 1096 C&A and n = 340 pediatricians. For the focus groups, a sample of 72 to 96 parents as well as pediatricians will be sought by using the method of theoretical sampling.
Around 560 pediatricians and 63,000 C&A currently participate in the AOK Nordost care program. The project provides information to what extent secondary preventive measures can lead to the early detection of diseases and on the associated cost-effectiveness. Furthermore, potentials and barriers of the program implementation are identified. The results of the evaluation study are expected not only to contribute to the further development of the care program, but also to derive recommendations for action.
German Clinical Trials Register (DRKS), DRKS-ID: DRKS00015280. Prospectively registered on 18 March 2019.
德国 AOK Nordost（一家德国法定健康保险公司）的“AOK-Junior”儿童和青少年保健计划（C&A）在德国柏林、勃兰登堡和梅克伦堡-前波莫瑞州完善了初级保健服务。该计划的重点是预防和及早发现 C&A 的疾病。此外，其目的是维持 C&A 的健康，及时预防、发现和治疗疾病。该计划的内容不仅包括 C&A 的综合护理，还包括例如 U10、U11 和 J2 的体重减轻和其他额外的体检。该综合干预措施的评估应提供有关早期疾病发现的有效性、成本效益以及其他参数（如满意度）的信息。
评估从结构、过程和结果质量三个层面进行。通过健康经济评估来评估成本效益。除了从参与和不参与的 C&A 和儿科医生收集定性和定量的初级数据外，还在评估中使用法定健康保险的常规数据。此外，采用横断面设计评估结构和过程质量。基于二次数据，在纵向部分设计中评估有效性。定量调查包括 1096 名 C&A 和 340 名儿科医生的净样本。对于焦点小组，将通过理论抽样的方法寻找 72 至 96 名父母和儿科医生的样本。
目前约有 560 名儿科医生和 63000 名 C&A 参与 AOK Nordost 保健计划。该项目提供了有关二级预防措施在多大程度上可以导致疾病的早期发现以及相关成本效益的信息。此外，还确定了计划实施的潜力和障碍。评估研究的结果不仅有助于进一步发展保健计划，还可以为行动提供建议。
德国临床试验注册处（DRKS），DRKS-ID：DRKS00015280。2019 年 3 月 18 日前瞻性注册。
